Global Pediatrics Partnering 2010-2017: Deal trends, players and financials

Publisher Name :
Date: 01-Feb-2017
No. of pages: 500

"Delivery of this report will take 1-3 days after purchase."

Summary

Global Pediatrics Partnering 2010-2017: Deal trends, players and financials provides comprehensive understanding and unprecedented access to the pediatrics partnering deals and agreements entered into by the worlds leading healthcare companies

Description

Global Pediatrics Partnering 2010 to 2017 provides the full collection of Pediatrics disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Trends in Pediatrics partnering deals

Financial deal terms for headline, upfront and royalty by stage of development

Pediatrics partnering agreement structure

Pediatrics partnering contract documents

Top Pediatrics deals by value

Most active Pediatrics dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Pediatrics disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Pediatrics deals.

The report presents financial deal terms values for Pediatrics deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Pediatrics dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Pediatrics dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Pediatrics deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Pediatrics dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Pediatrics deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Pediatrics partnering deals by specific Pediatrics target announced since 2010. The chapter is organized by specific Pediatrics therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Pediatrics partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Pediatrics partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Pediatrics technologies and products.

Report scope

Global Pediatrics Partnering 2010 to 2017 is intended to provide the reader with an in-depth understanding and access to Pediatrics trends and structure of deals entered into by leading companies worldwide.

Global Pediatrics Partnering 2010 to 2017 includes:

Trends in Pediatrics dealmaking in the biopharma industry since 2010

Analysis of Pediatrics deal structure

Access to headline, upfront, milestone and royalty data

Access to hundreds of Pediatrics deal contract documents

Comprehensive access to over 3500 Pediatrics deal records

The leading Pediatrics deals by value since 2010

Most active Pediatrics dealmakers since 2010

In Global Pediatrics Partnering 2010 to 2017, available deals and contracts are listed by:

Headline value

Upfront payment value

Royalty rate value

Stage of development at signing

Deal component type

Technology type

Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Pediatrics Partnering 2010-2017 report provides comprehensive access to available deals and contract documents for over 200 pediatrics deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are the sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Pediatrics Partnering 2010 to 2017 provides the reader with the following key benefits:

In-depth understanding of Pediatrics deal trends since 2010

Access Pediatrics deal headline, upfront, milestone and royalty data

Research hundreds of actual contracts between Pediatrics partner companies

Comprehensive access to over 750 links to actual Pediatrics deals entered into by the world's biopharma companies

Indepth review of Pediatrics deals entered into by the top 25 most active dealmakers

Benchmark the key deal terms companies have agreed in previous deals

Identify key terms under which companies partner Pediatrics opportunities

Uncover companies actively partnering Pediatrics opportunities

Global Pediatrics Partnering 2010-2017: Deal trends, players and financials

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Pediatrics dealmaking
2.1. Introduction
2.2. Pediatrics partnering over the years
2.3. Pediatrics partnering by deal type
2.4. Pediatrics partnering by industry sector
2.5. Pediatrics partnering by stage of development
2.6. Pediatrics partnering by technology type
2.7. Pediatrics partnering by therapeutic indication

Chapter 3 -Financial deal terms for Pediatrics partnering
3.1. Introduction
3.2. Disclosed financials terms for Pediatrics partnering
3.3. Pediatrics partnering headline values
3.4. Pediatrics deal upfront payments
3.5. Pediatrics deal milestone payments
3.6. Pediatrics royalty rates

Chapter 4 - Leading Pediatrics deals and dealmakers
4.1. Introduction
4.2. Most active in Pediatrics partnering
4.3. List of most active dealmakers in Pediatrics
4.4. Top Pediatrics deals by value

Chapter 5 - Pediatrics contract document directory
5.1. Introduction
5.2. Pediatrics partnering deals where contract document available

Chapter 6 - Pediatrics dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Pediatrics therapeutic target
Appendices
Appendix 1 - Directory of Pediatrics deals by company A-Z 2010 to 2017
Appendix 2 - Directory of Pediatrics deals by deal type 2010 to 2017
Appendix 3 - Directory of Pediatrics deals by stage of development 2010 to 2017
Appendix 4 - Directory of Pediatrics deals by technology type 2010 to 2017
Further reading on dealmaking
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

List of Figures

Figure 1: Pediatrics partnering since 2010
Figure 2: Pediatrics partnering by deal type since 2010
Figure 3: Pediatrics partnering by industry sector since 2010
Figure 4: Pediatrics partnering by stage of development since 2010
Figure 5: Pediatrics partnering by technology type since 2010
Figure 6: Pediatrics partnering by indication since 2010
Figure 7: Pediatrics deals with a headline value
Figure 8: Pediatrics deals with upfront payment values
Figure 9: Pediatrics deals with milestone payment
Figure 10: Pediatrics deals with royalty rates
Figure 11: Active Pediatrics dealmaking activity- 2010 to 2017
Figure 12: Top Pediatrics deals by value since 2010
  • Global Vegetarian Softgel Capsules Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 21-Feb-2017        Price: US 3480 Onwards        Pages: 118
    Vegetarian Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Scope of the Report: This report focuses on the Vegetarian Softgel Capsules in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, typ......
  • Europe Vegetarian Softgel Capsules Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 21-Feb-2017        Price: US 4480 Onwards        Pages: 118
    Vegetarian Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Scope of the Report: This report focuses on the Vegetarian Softgel Capsules in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application. Mar......
  • Global Tuberculin Sales Market Report 2017
    Published: 20-Feb-2017        Price: US 4000 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Tuberculin Revenue, means the sales value of Tuberculin This report studies sales (consumption) of Tuberculin in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Sanofi Pasteur Inc - Zoetis - Par Pharmaceutica/JHP Pharmaceuticals - Beijing San......
  • Global Acarbose Sales Market Report 2017
    Published: 20-Feb-2017        Price: US 4000 Onwards        Pages: 111
    Notes: Sales, means the sales volume of Acarbose Revenue, means the sales value of Acarbose This report studies sales (consumption) of Acarbose in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Pfizer - Beijing Bayer Healthcare - Novartis - Mylan - Squibb - Hikma Pha......
  • Global Conjugate Vaccine Sales Market Report 2017
    Published: 20-Feb-2017        Price: US 4000 Onwards        Pages: 119
    Notes: Sales, means the sales volume of Conjugate Vaccine Revenue, means the sales value of Conjugate Vaccine This report studies sales (consumption) of Conjugate Vaccine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Astellas Pharma Inc - CSL Limited - Emergent BioSolutions - ......
  • Global Immunostimulatory Adjuvants Sales Market Report 2017
    Published: 20-Feb-2017        Price: US 4000 Onwards        Pages: 112
    Notes: Sales, means the sales volume of Immunostimulatory Adjuvants Revenue, means the sales value of Immunostimulatory Adjuvants This report studies sales (consumption) of Immunostimulatory Adjuvants in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Araclon Biotech - Artificial Cell Technologi......
  • Global Zika Virus Market 2017 Industry Trend and Forecast 2021
    Published: 20-Feb-2017        Price: US 2800 Onwards        Pages: 116
    The Global Zika Virus Market 2016 Industry Trend and Forecast 2021 is a professional and in-depth study on the current state of the Zika Virus industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Zika Virus market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. ......
  • Global Cell Surface Markers Sales Market Report 2017
    Published: 20-Feb-2017        Price: US 4000 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Cell Surface Markers Revenue, means the sales value of Cell Surface Markers This report studies sales (consumption) of Cell Surface Markers in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Abbott - Beckman Coulter - BD - Bio-Rad - Gr......
  • Global Central Nervous System (CNS) Biomarkers Sales Market Report 2017
    Published: 20-Feb-2017        Price: US 4000 Onwards        Pages: 100
    Notes: Sales, means the sales volume of Central Nervous System (CNS) Biomarkers Revenue, means the sales value of Central Nervous System (CNS) Biomarkers This report studies sales (consumption) of Central Nervous System (CNS) Biomarkers in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - AbaStar MDX......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs